ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…